Intellectual Property

  • February 20, 2026

    7th Circ. Wary Of Tackling Jurisdiction In 2 'Schedule A' Suits

    Facing requests to address alleged jurisdictional shortcomings against e-commerce platforms in two mass counterfeiting cases Friday, a Seventh Circuit panel signaled that such discussion seems unwarranted in one vendor's fee appeal while resolving the issue separately for an e-commerce intermediary might be inappropriate given its unclear case record.

  • February 20, 2026

    Ex-Exec Must Arbitrate Claims In CoStar DQ-Embroiled Spat

    A California federal judge sent most of a former Matterport executive's harassment and retaliation suit to arbitration, amid a suit that has prompted CoStar's efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel in separate litigation.

  • February 20, 2026

    BioNTech Says Moderna's New COVID Vax Infringes Its IP

    BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal court.

  • February 20, 2026

    Squires Sinks 2 PTAB Challenges, Including 1 He Instituted

    U.S. Patent and Trademark Office Director John Squires has reversed his own decision and another made by the Patent Trial and Appeal Board to institute a pair of America Invents Act petitions, citing what he called the challengers' inconsistent claim construction.

  • February 20, 2026

    Fed. Circ. Backs PTAB Invalidation Of VideoLabs Patent Claims

    The Federal Circuit on Friday upheld a decision by the Patent Trial and Review Board that most of the challenged claims in a VideoLabs Collective patent for synchronizing data are invalid, finding VideoLabs had forfeited its argument by raising it for the first time before the circuit.

  • February 20, 2026

    Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP

    The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible. 

  • February 20, 2026

    Fed. Circ. OKs Micron's PTAB Loss In Netlist Patent Challenge

    The Federal Circuit on Friday upheld Patent Trial and Appeal Board decisions that Micron Technology Inc. failed to show that claims of a Netlist Inc. computer memory patent are invalid, part of a wide-ranging dispute that includes a nine-figure verdict against Micron on other patents.

  • February 20, 2026

    Dinsmore Adds IP Partner In Texas From Fish & Richardson

    Dinsmore & Shohl LLP has hired a Fish & Richardson PC intellectual property lawyer who has advanced degrees in mechanical and aerospace engineering and practiced at his previous firm for more than 20 years, the firm announced Wednesday.

  • February 20, 2026

    2nd Circ. Backs $286K For Childish Gambino's Attys

    The Second Circuit has approved a $286,000 attorney fee award granted to lawyers representing rapper Childish Gambino and his record label in a case from another rapper who alleged part of the hit song "This Is America" was lifted from one of his tracks.

  • February 20, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.

  • February 19, 2026

    Ex-Google Engineers Took Trade Secrets To Iran, DOJ Says

    Three Silicon Valley engineers exploited their employment at Google and other major tech companies in order to steal trade secrets and send the confidential information to personal devices that they then accessed in Iran, the U.S. Department of Justice said Thursday.

  • February 19, 2026

    Lab Seeks Rare Essential Patent Injunction In Wi-Fi Case

    Citing recent encouragement from federal agencies, a Korean research lab is seeking a rare permanent injunction in a case involving standard essential patents, after a unit of Taiwan's Asus stipulated that its routers infringe the lab's essential Wi-Fi patents.

  • February 19, 2026

    Trump's Push For Airport TMs Unprecedented, Experts Say

    President Donald Trump's effort to register trademarks for airports that could someday bear his name represents a striking break from how past presidents have gotten their names placed on landmarks, intellectual property attorneys say.

  • February 19, 2026

    Justices Urged To Bar Passive Infringement For Skinny Labels

    The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme Court in a case over so-called skinny labels.

  • February 19, 2026

    Producers Drop Karol G 'Gatúbela' Suit, Issue Apology

    Two music producers who accused star Colombian singer Karol G and Universal Music Group of lifting the beat from their track for her hit song "Gatúbela" told a Florida federal court Wednesday that they are dropping their claims and will publicly apologize.

  • February 19, 2026

    Funder Longford Wins Patent Litigation Settlement Dispute

    Litigation funder Longford Capital has prevailed in arbitration relating to a dispute with Arigna Technology Ltd. over a settlement that ended certain patent litigation, according to documents filed in Delaware federal court.

  • February 19, 2026

    Judge Affirms Literal Infringement In Ravgen's $57M Jury Win

    A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.

  • February 19, 2026

    Shkreli Again Tries To Add Wu-Tang Members To Album Fight

    "Pharma Bro" Martin Shkreli filed a third-party complaint against two members of hip-hop group Wu-Tang Clan, seeking once again to bring them into litigation brought by a cryptocurrency community that claims Shkreli improperly retained copies of a Wu-Tang album the community had bought the rights to.

  • February 19, 2026

    Flavored Air Co. Seeks Ch. 15 Nod In Nevada After Settlement

    A Canadian flavored air device company is asking a Nevada bankruptcy judge to recognize the Canadian insolvency proceedings it began earlier this month after falling behind in payments from the settlement of a U.S. trademark infringement suit.

  • February 19, 2026

    She Has A Point: Dechert's Kassie Helm

    Kassie Helm, co-chair of Dechert LLP's global intellectual property group and head of its IP litigation group, is "unquestionably one of the leading lights of her generation," according to Morrison Foerster LLP partner Daralyn Durie, who praised Helm for her work as opposing counsel in a new series celebrating women litigators.

  • February 19, 2026

    Squires Accepts 8 PTAB Cases, Walks Back 7 Merits Referrals

    A bulk summary order from U.S. Patent and Trademark Office Director John Squires granted eight petitions for America Invents Act patent challenges while denying 14 others, including seven that he had previously accepted for merits-based review.

  • February 19, 2026

    Fed. Circ. OKs Decision Clearing Sony In $500M Patent Case

    The Federal Circuit on Thursday upheld a decision that Sony's PlayStation controllers do not infringe a computer input device patent, in a case where Sony said patent owner Genuine Enabling Technology was seeking nearly $500 million in damages.

  • February 19, 2026

    Fed. Circ. Won't Revive Corcept's Drug Patent Feud

    The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.

  • February 19, 2026

    Foley & Lardner Brings On 4 IP, Corporate Attys In Calif.

    Foley & Lardner LLP is expanding its California team, announcing Thursday it is adding four partners with technology-related experience — two in San Diego, one in San Francisco and one in Silicon Valley.

  • February 19, 2026

    Tech Co. Seeks Morgan Lewis DQ From Smart Glasses Case

    A Hong Kong-based tech company has asked a Massachusetts federal judge to kick Morgan Lewis & Bockius LLP off of a case in which it's accusing Meta Platforms and Oakley Inc. of infringing patents with their smart glasses technology.

Expert Analysis

  • The Pros And Cons Of Levying Value-Based Fees On Patents

    Author Photo

    The potential for a recurring, value-based maintenance fee on patents, while offering some benefits, raises several complications, including that it would likely exceed the U.S. Patent and Trademark Office's statutory authority and reduce research and development activities in the U.S., says Sandip Patel at Marshall Gerstein.

  • Strategies To Get The Most Out Of A Mock Jury Exercise

    Author Photo

    A Florida federal jury’s recent $329 million verdict against Tesla over a fatal crash demonstrates how jurors’ perceptions of nuanced facts can make or break a case, and why attorneys must maximize the potential of their mock jury exercises to pinpoint the best trial strategy, says Jennifer Catero at Snell & Wilmer.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Between The Lines Of EPO's Adoption Of Color Drawings

    Author Photo

    The European Patent Office's decision to accept patent drawings in color starting in October may enhance clarity in technical disclosures and streamline the examination process, and could also enable new patent filing strategies for international applicants, say attorneys at Miller Canfield.

  • Series

    Adapting To Private Practice: From Va. AUSA To Mid-Law

    Author Photo

    Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.

  • 2 Fed. Circ. Rulings Underscore Patent Prosecution Pitfalls

    Author Photo

    Two recent patent decisions from the Federal Circuit, overturning significant judgments, serve as reminders that claim modifications and cancellations may have substantive effects on the scope of other claims, and that arguments distinguishing prior art and characterizing claims may also limit claim scope, say attorneys at Morgan Lewis.

  • 7 Document Review Concepts New Attorneys Need To Know

    Author Photo

    For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.

  • Fed. Circ. Rulings Refine Patent Claim Construction Standards

    Author Photo

    Four Federal Circuit patent decisions this year clarify several crucial principles governing patent claim construction, including the importance of prosecution history, and the need for error-free, precise language from claims drafters, say attorneys at Taft.

  • Avoiding Unforced Evidentiary Errors At Trial

    Author Photo

    To avoid self-inflicted missteps at trial, lawyers must plan their evidentiary strategy as early as their claims and defenses, with an eye toward some of the more common pitfalls, says Nate Sabri at Perkins Coie.

  • How Value-Based Patent Fees May Shape IP Strategies

    Author Photo

    If the U.S. Patent and Trademark Office implements rumored plans to correlate patent fees with patent value, the financial and strategic consequences would largely depend on the specifics of how, when and how often patent values are assessed, say attorneys at Cleary.

  • Agentic AI Puts A New Twist On Attorney Ethics Obligations

    Author Photo

    As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.

  • Using Reissue Applications To Strategically Improve Patents

    Author Photo

    Though reissue applications are an often-overlooked consideration in today's patent environment, they can offer powerful tools for correcting errors, strengthening patent protection, or adapting to evolving business and legal landscapes, says Curtis Powell at Wolf Greenfield.

  • Series

    Being A Professional Wrestler Makes Me A Better Lawyer

    Author Photo

    Pursuing my childhood dream of being a professional wrestler has taught me important legal career lessons about communication, adaptability, oral advocacy and professionalism, says Christopher Freiberg at Midwest Disability.

  • Patent Claim Lessons From Fed. Circ.'s Teva Decision

    Author Photo

    The Federal Circuit's recent decision in Janssen v. Teva is an important precedent for parties drafting patent claims or litigating obviousness where the prior art has potentially overlapping ranges for a claimed element, and may be particularly instructive to patent applicants in the pharmaceutical field, say attorneys at Cooley.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.